Tomasz Kraj
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tomasz Kraj has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Janusz Strzelczyk
Department of General and Transplant Surgery, Medical University of Lodz, 90-419 Lodz, Poland
3 shared publications - Oliwia Grząsiak-Kraj
Department of General and Transplant Surgery, Medical University of Lodz, 90-419 Lodz, Poland
3 shared publications - Krzysztof Poznański
Department of General and Transplant Surgery, Norbert Barlicki Memorial Teaching Hospital No. 1, Medical University of Lodz, 22 Kopcinskiego Street, 90-153 Lodz, Poland
2 shared publications - Adam Durczyński
Department of General and Transplant Surgery, Medical University of Lodz, 90-419 Lodz, Poland
1 shared publication - Adam Durczyński
Department of General and Transplant Surgery, Norbert Barlicki Memorial Teaching Hospital No. 1, Medical University of Lodz, 22 Kopcinskiego Street, 90-153 Lodz, Poland
1 shared publication - Agata Grochowska
Department of General and Transplant Surgery, Medical University of Lodz, Łódź, Poland
1 shared publication
Latest Publications
- Open Access
- 8 September 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (9) , 2020
Clinical Evaluation of Postoperative Day 3 Serum Lipase in Relation to Clinically Relevant Pancreatic Fistula After Distal Pancreatectomy: A Retrospective Cohort Study
Background/Objectives: Clinically relevant postoperative pancreatic fistula (CR-POPF) remains a major complication after distal pancreatectomy. Postoperative pancreatic enzyme elevation is increasingly recognized as a marker of pancreatic remnant injury, but serum lipase after distal pancreatectomy has been less well characterized than serum amylase and drain-fluid markers. This study evaluated postoperative day 3 (POD3) serum lipase as a routine biochemical marker associated with CR-POPF. Methods: We retrospectively analyzed 202 consecutive adults who underwent distal pancreatectomy between 2016 and 2026. CR-POPF was defined as International Study Group on Pancreatic Surgery grade B or C. POD3 lipase was available in 157 patients, including 17 CR-POPF events. Results: POD3 lipase was higher in patients with CR-POPF than in those without it (median 74 vs. 31 U/L; p < 0.001). Each doubling of lipase was associated with higher odds of CR-POPF (OR 2.59, 95% CI 1.54–4.37). The AUC was 0.79 (95% CI 0.67–0.90) and remained 0.79 after bootstrap optimism correction. At 64 U/L, the negative predictive value was 96%; at 3 × ULN, specificity was 99%. Conclusions: POD3 serum lipase provides a readily available serum biochemical marker, not requiring drain-fluid sampling, associated with CR-POPF after distal pancreatectomy. The findings are exploratory and require external validation before clinical implementation.
- 8 September 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (9) , 2020
Open AccessClinical Evaluation of Postoperative Day 3 Serum Lipase in Relation to Clinically Relevant Pancreatic Fistula After Distal Pancreatectomy: A Retrospective Cohort Study
Background/Objectives: Clinically relevant postoperative pancreatic fistula (CR-POPF) remains a major complication after distal pancreatectomy. Postoperative pancreatic enzyme elevation is increasingly recognized as a marker of pancreatic remnant injury, but serum lipase after distal pancreatectomy has been less well characterized than serum amylase and drain-fluid markers. This study evaluated postoperative day 3 (POD3) serum lipase as a routine biochemical marker associated with CR-POPF. Methods: We retrospectively analyzed 202 consecutive adults who underwent distal pancreatectomy between 2016 and 2026. CR-POPF was defined as International Study Group on Pancreatic Surgery grade B or C. POD3 lipase was available in 157 patients, including 17 CR-POPF events. Results: POD3 lipase was higher in patients with CR-POPF than in those without it (median 74 vs. 31 U/L; p < 0.001). Each doubling of lipase was associated with higher odds of CR-POPF (OR 2.59, 95% CI 1.54–4.37). The AUC was 0.79 (95% CI 0.67–0.90) and remained 0.79 after bootstrap optimism correction. At 64 U/L, the negative predictive value was 96%; at 3 × ULN, specificity was 99%. Conclusions: POD3 serum lipase provides a readily available serum biochemical marker, not requiring drain-fluid sampling, associated with CR-POPF after distal pancreatectomy. The findings are exploratory and require external validation before clinical implementation.
- Open Access
Perioperative Thyroid-Metabolic Changes in Pancreatic Ductal Adenocarcinoma According to Surgical Management
Background: Pancreatic ductal adenocarcinoma (PDAC) is associated not only with tumor progression but also with profound metabolic and nutritional disturbances. Thyroid hormone homeostasis may reflect this systemic response; however, perioperative data in PDAC remain limited. We aimed to assess perioperative changes in thyroid-related parameters in patients with PDAC undergoing different types of surgical management and to explore their associations with nutritional, metabolic, and tumor-burden variables. Methods: We performed a retrospective single-center study including 101 patients with PDAC. Thyroid-related and metabolic laboratory parameters were assessed before surgery and again 4–6 weeks later. The analyzed variables included thyroid-stimulating hormone (TSH), free triiodothyronine (FT3), free thyroxine (FT4), the FT3/FT4 ratio, albumin, total protein, glucose, insulin, HbA1c, lipid parameters, and CA 19-9. Patients were analyzed according to resectional versus non-resectional treatment and according to four procedure types. The primary endpoint was perioperative change in the FT3/FT4 ratio. Results: At baseline, resectional patients had significantly higher FT3 and FT3/FT4 ratio values and lower FT4 and CA 19-9 levels than non-resectional patients. In the whole cohort, FT3 and the FT3/FT4 ratio decreased significantly after treatment, whereas TSH increased, and FT4 remained unchanged. These endocrine changes occurred in parallel with significant declines in albumin, total protein, glucose, insulin, HbA1c, and HDL cholesterol, together with an increase in triglyceride levels. Baseline FT3 and FT3/FT4 ratios correlated positively with albumin and total protein and negatively with CA 19-9. Although perioperative changes did not differ significantly between resectional and non-resectional groups except for triglycerides, significant procedure-dependent differences were observed across the four surgical categories for FT3, FT4, TSH, and the FT3/FT4 ratio; glucose; insulin; and triglycerides. The prevalence of low-T3 syndrome increased from 11.1% preoperatively to 38.7% postoperatively. Conclusions: In PDAC, perioperative changes in thyroid hormone indices are pronounced and strongly depend on the type of surgical management. FT3 and the FT3/FT4 ratio appear to reflect systemic metabolic and nutritional adaptation as well as disease burden rather than acting as tumor-specific markers.
Open AccessPerioperative Thyroid-Metabolic Changes in Pancreatic Ductal Adenocarcinoma According to Surgical Management
Background: Pancreatic ductal adenocarcinoma (PDAC) is associated not only with tumor progression but also with profound metabolic and nutritional disturbances. Thyroid hormone homeostasis may reflect this systemic response; however, perioperative data in PDAC remain limited. We aimed to assess perioperative changes in thyroid-related parameters in patients with PDAC undergoing different types of surgical management and to explore their associations with nutritional, metabolic, and tumor-burden variables. Methods: We performed a retrospective single-center study including 101 patients with PDAC. Thyroid-related and metabolic laboratory parameters were assessed before surgery and again 4–6 weeks later. The analyzed variables included thyroid-stimulating hormone (TSH), free triiodothyronine (FT3), free thyroxine (FT4), the FT3/FT4 ratio, albumin, total protein, glucose, insulin, HbA1c, lipid parameters, and CA 19-9. Patients were analyzed according to resectional versus non-resectional treatment and according to four procedure types. The primary endpoint was perioperative change in the FT3/FT4 ratio. Results: At baseline, resectional patients had significantly higher FT3 and FT3/FT4 ratio values and lower FT4 and CA 19-9 levels than non-resectional patients. In the whole cohort, FT3 and the FT3/FT4 ratio decreased significantly after treatment, whereas TSH increased, and FT4 remained unchanged. These endocrine changes occurred in parallel with significant declines in albumin, total protein, glucose, insulin, HbA1c, and HDL cholesterol, together with an increase in triglyceride levels. Baseline FT3 and FT3/FT4 ratios correlated positively with albumin and total protein and negatively with CA 19-9. Although perioperative changes did not differ significantly between resectional and non-resectional groups except for triglycerides, significant procedure-dependent differences were observed across the four surgical categories for FT3, FT4, TSH, and the FT3/FT4 ratio; glucose; insulin; and triglycerides. The prevalence of low-T3 syndrome increased from 11.1% preoperatively to 38.7% postoperatively. Conclusions: In PDAC, perioperative changes in thyroid hormone indices are pronounced and strongly depend on the type of surgical management. FT3 and the FT3/FT4 ratio appear to reflect systemic metabolic and nutritional adaptation as well as disease burden rather than acting as tumor-specific markers.
- Open Access
- 31 January 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (2) , 326
Impact of Palliative Gastrojejunostomy Type on Survival in Patients with Unresectable Pancreatic Head Cancer: A Retrospective Analysis
Gastrojejunostomy (GJ) is used as a palliative procedure in patients with inoperable pancreatic head cancer. While its primary goal is to relieve obstruction, clinical observations suggest the type of reconstruction may influence survival. Objectives: The objective of this study was to compare overall survival in patients undergoing different types of palliative gastrojejunostomy. Methods: A retrospective analysis was performed on 240 patients with inoperable pancreatic cancer. Patients were divided into three groups: Roux-en-Y (n = 186), Omega loop with Braun anastomosis (n = 36), and simple Omega loop (n = 18). A multivariable Cox proportional hazards model was used to assess the risk of death, adjusting for age and sex. Results: In the multivariable analysis, the Roux-en-Y anastomosis was associated with a significantly lower risk of death compared to the simple Omega loop (HR = 0.47; 95% CI: 0.28–0.79; p = 0.004). Similarly, the Omega loop with Braun anastomosis demonstrated a significant survival benefit compared to the simple Omega loop (HR = 0.50; 95% CI: 0.27–0.93; p = 0.029). Age was a significant independent predictor of mortality. Conclusions: The type of gastrojejunostomy significantly influences survival in patients with advanced pancreatic cancer. Both Roux-en-Y and Omega with Braun anastomosis offer superior survival outcomes compared to simple Omega loop gastrojejunostomy. These benefits may be attributable to complex metabolic and hormonal mechanisms, which warrant further investigation in prospective studies.
- 31 January 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (2) , 326
Open AccessImpact of Palliative Gastrojejunostomy Type on Survival in Patients with Unresectable Pancreatic Head Cancer: A Retrospective Analysis
Gastrojejunostomy (GJ) is used as a palliative procedure in patients with inoperable pancreatic head cancer. While its primary goal is to relieve obstruction, clinical observations suggest the type of reconstruction may influence survival. Objectives: The objective of this study was to compare overall survival in patients undergoing different types of palliative gastrojejunostomy. Methods: A retrospective analysis was performed on 240 patients with inoperable pancreatic cancer. Patients were divided into three groups: Roux-en-Y (n = 186), Omega loop with Braun anastomosis (n = 36), and simple Omega loop (n = 18). A multivariable Cox proportional hazards model was used to assess the risk of death, adjusting for age and sex. Results: In the multivariable analysis, the Roux-en-Y anastomosis was associated with a significantly lower risk of death compared to the simple Omega loop (HR = 0.47; 95% CI: 0.28–0.79; p = 0.004). Similarly, the Omega loop with Braun anastomosis demonstrated a significant survival benefit compared to the simple Omega loop (HR = 0.50; 95% CI: 0.27–0.93; p = 0.029). Age was a significant independent predictor of mortality. Conclusions: The type of gastrojejunostomy significantly influences survival in patients with advanced pancreatic cancer. Both Roux-en-Y and Omega with Braun anastomosis offer superior survival outcomes compared to simple Omega loop gastrojejunostomy. These benefits may be attributable to complex metabolic and hormonal mechanisms, which warrant further investigation in prospective studies.